Terms: = Breast cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Clinical Outcome
9 results:
1. miR‑378a‑3p inhibits cellular proliferation and migration in glioblastoma multiforme by targeting tetraspanin 17.
Guo XB; Zhang XC; Chen P; Ma LM; Shen ZQ
Oncol Rep; 2019 Nov; 42(5):1957-1971. PubMed ID: 31432186
[TBL] [Abstract] [Full Text] [Related]
2. clinical outcome of Prostate cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study.
Mateo J; Cheng HH; Beltran H; Dolling D; Xu W; Pritchard CC; Mossop H; Rescigno P; Perez-Lopez R; Sailer V; Kolinsky M; Balasopoulou A; Bertan C; Nanus DM; Tagawa ST; Thorne H; Montgomery B; Carreira S; Sandhu S; Rubin MA; Nelson PS; de Bono JS
Eur Urol; 2018 May; 73(5):687-693. PubMed ID: 29429804
[TBL] [Abstract] [Full Text] [Related]
3. Lippia origanoides extract induces cell cycle arrest and apoptosis and suppresses NF-κB signaling in triple-negative breast cancer cells.
Raman V; Fuentes Lorenzo JL; Stashenko EE; Levy M; Levy MM; Camarillo IG
Int J Oncol; 2017 Dec; 51(6):1801-1808. PubMed ID: 29075784
[TBL] [Abstract] [Full Text] [Related]
4. LAG-3+ tumor infiltrating lymphocytes in breast cancer: clinical correlates and association with PD-1/PD-L1+ tumors.
Burugu S; Gao D; Leung S; Chia SK; Nielsen TO
Ann Oncol; 2017 Dec; 28(12):2977-2984. PubMed ID: 29045526
[TBL] [Abstract] [Full Text] [Related]
5. Association of XPC polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients.
Yang X; Liu D; Wu H; Kang H; Pang H; Huang D; Sha X; Wang E; Wang Z; Wei M
Cancer Sci; 2012 Jul; 103(7):1207-14. PubMed ID: 22519360
[TBL] [Abstract] [Full Text] [Related]
6. Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features.
Festa-Vasconcellos JS; Piranda DN; Amaral LM; Indio-do-Brasil V; Koifman S; Vianna-Jorge R
Breast Cancer Res Treat; 2012 Feb; 132(1):251-8. PubMed ID: 22037828
[TBL] [Abstract] [Full Text] [Related]
7. Amplification of a 280-kilobase core region at the ERBB2 locus leads to activation of two hypothetical proteins in breast cancer.
Kauraniemi P; Kuukasjärvi T; Sauter G; Kallioniemi A
Am J Pathol; 2003 Nov; 163(5):1979-84. PubMed ID: 14578197
[TBL] [Abstract] [Full Text] [Related]
8. Comparison between different cell kinetic variables in human breast cancer.
Barzanti F; Dal Susino M; Volpi A; Amadori D; Riccobon A; Scarpi E; Medri L; Bernardi L; Naldi S; Aldi M; Gaudio M; Zoli W
Cell Prolif; 2000 Apr; 33(2):75-89. PubMed ID: 10845252
[TBL] [Abstract] [Full Text] [Related]
9. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition.
Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Evans SR
Cancer Res; 1993 Aug; 53(16):3712-8. PubMed ID: 8393379
[TBL] [Abstract] [Full Text] [Related]
